312 related articles for article (PubMed ID: 8390746)
1. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells.
Hiraiwa A; Kiyono T; Segawa K; Utsumi KR; Ohashi M; Ishibashi M
Virology; 1993 Jan; 192(1):102-11. PubMed ID: 8390746
[TBL] [Abstract][Full Text] [Related]
2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
4. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
7. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger K; Scheffner M; Huibregtse JM; Howley PM
Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
9. [The biological activities of the human papillomavirus type 16 E6/E7 cDNAs cloned from the SiHa cervical carcinoma cell line].
Tamada Y
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):849-61. PubMed ID: 8112710
[TBL] [Abstract][Full Text] [Related]
10. The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression?
Bosch FX; Dürst M; Schwarz E; Boukamp P; Fusenig NE; zur Hausen H
Behring Inst Mitt; 1991 Jul; (89):108-21. PubMed ID: 1656929
[TBL] [Abstract][Full Text] [Related]
11. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
Vousden KH; Doniger J; DiPaolo JA; Lowy DR
Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339
[TBL] [Abstract][Full Text] [Related]
12. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
14. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
15. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells.
Storey A; Banks L
Oncogene; 1993 Apr; 8(4):919-24. PubMed ID: 8384359
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
Tan TM; Ting RC
Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636
[TBL] [Abstract][Full Text] [Related]
18. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6.
Inoue T; Oka K; Yong-Il H; Vousden KH; Kyo S; Jing P; Hakura A; Yutsudo M
Mol Carcinog; 1998 Mar; 21(3):215-22. PubMed ID: 9537653
[TBL] [Abstract][Full Text] [Related]
19. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
20. HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs).
Braun K; Ehemann V; Waldeck W; Pipkorn R; Corban-Wilhelm H; Jenne J; Gissmann L; Debus J
Cancer Lett; 2004 Jun; 209(1):37-49. PubMed ID: 15145519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
